![Bernard Davitian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernard Davitian
Directeur/Membre du Conseil chez
Vanqua Bio, Inc.
Profil
Bernard Davitian was the founder of DNA Therapeutics SASU, founded in 2009, where the title held was Director in 2009.
Current jobs include Director at Vanqua Bio, Inc. since 2021, Director at Endeavor BioMedicines, Inc., and Partner at Omega Fund Management LLC since 2020.
Former jobs include Chief Executive Officer at Neurotech Pharmaceuticals, Inc. (2005–2006), Vice President & Managing Director at Sanofi Ventures LLC (2012–2019), Director at Proteostasis Therapeutics, Inc., Director at KAHR Medical Ltd., Director at Lysosomal Therapeutics, Inc., Director at Upstream Bio, Inc. (2021–2023), Independent Director at Lexeo Therapeutics, Inc. (2020–2024), Chief Financial Officer & Executive Vice President at Transgene SA (1995–2000), Executive Vice President & Chief Financial Officer at Fovea Pharmaceuticals SA (2006–2010), Chief Financial Officer at Sanofi Pasteur SA (1994), Chief Financial Officer at Pasteur Merieux, Inc. (1994), Chief Financial Officer at Fortel Invest Oy (2000–2001), and Senior Auditor at Arthur Andersen LLP (1984–1986).
Education includes graduation from EM Lyon Business School in 1981 and an MBA from The Wharton School of the University of Pennsylvania in 1994.
Postes actifs de Bernard Davitian
| Sociétés | Poste | Début |
|---|---|---|
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Private Equity Investor | 01/01/2020 |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Directeur/Membre du Conseil | - |
Vanqua Bio, Inc.
 Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Directeur/Membre du Conseil | 01/08/2021 |
Anciens postes connus de Bernard Davitian
| Sociétés | Poste | Fin |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/06/2024 |
| UPSTREAM BIO, INC. | Directeur/Membre du Conseil | 30/06/2023 |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Directeur Général | 01/10/2019 |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Directeur Financier/CFO | 31/12/2010 |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Directeur Général | 01/01/2006 |
Formation de Bernard Davitian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Health Technology |
Pasteur Merieux, Inc. | |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Fortel Invest Oy
 Fortel Invest Oy Investment ManagersFinance Fortel Invest seeks investment opportunities in companies located in Finland. The firm targets companies operating in clean energy and environmental technology businesses. It provides financing for growth stage capital requirements. | Finance |
DNA Therapeutics SASU
 DNA Therapeutics SASU BiotechnologyHealth Technology Engages in the development of drugs for cancer treatment | Health Technology |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
Endeavor BioMedicines, Inc
Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Commercial Services |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
